Breckenridge announces final FDA approval for Everolimus tablets for oral suspension, AB-rated to AFINITOR DISPERZ®

BERKELEY HEIGHTS, N.J., Jan. 29, 2025 /PRNewswire/ — Breckenridge Pharmaceutical, Inc., -the U.S. subsidiary of Towa International that markets, distributes, and sells generic pharmaceuticals in the United States, – announced today that the Food and Drug Administration (FDA) has granted…